Bristol-Myers Squibb moving 90 manufacturing jobs from New York facility

Bristol-Myers Squibb building
The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. (Bristol-Myers Squibb)

Bristol-Myers Squibb will move about 90 manufacturing jobs from its DeWitt, New York, facility to plants in Massachusetts and New Jersey.

The changes are part of the company’s restructuring efforts, Pharmafile reported.

Lisa McCormick Lavery, the company’s director of corporate communications, told the publication that the moves are part of a plan to consolidate related positions within the company that includes transferring other positions from company facilities in Connecticut, Indiana and Seattle to the same two sites.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. 

The change is expected to be completed by first-quarter 2019; however, they are not expected to have an effect on manufacturing operations at the DeWitt facility.

Suggested Articles

The FDA has delayed its review of Revance's frown-line injection candidate after it failed to inspect a key manufacturing facility on time.

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

United Airlines last week delivered the first doses of Pfizer's vaccine from Belgium to the U.S. as the drugmaker preps for a potential December nod.